INQ000257098 – Press release mula sa Medicines and Healthcare products Regulatory Agency na pinamagatang First oral antiviral para sa COVID-19, Lagevrio (molnupiravir), na inaprubahan ng MHRA, na may petsang 04/11/2021.

Press release mula sa Medicines and Healthcare products Regulatory Agency na pinamagatang First oral antiviral para sa COVID-19, Lagevrio (molnupiravir), na inaprubahan ng MHRA, na may petsang 04/11/2021.

I-download ang dokumentong ito

• English (PDF)